I’d forget the FTSE 250 and buy this growth stock instead

This FTSE 250 (INDEXFTSE:MCX) growth stock has recently underperformed its index. Paul Summers thinks this could be about to change.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Last month, I said that I would have no issue buying shares in FTSE 250 critical components supplier XP Power (LSE: XPP) before it releases interim results. Based on today’s numbers, it would appear this was a good call.  

“Continued strength”

Thanks to “continued strength” in the semiconductor manufacturing equipment sector and a rebound in industrial technology, revenue was 14% higher over the first six months of 2021 compared to the previous year.

XPP’s bottom line fared even better. Reported pre-tax profit came in a whopping 59% higher at £16.4m. That’s a fine result on its own. However, it’s particularly good given that trading from the healthcare sector normalised as expected. 

At a time when some companies are being hurt by inflation, existing holders may also be comforted by news that XP’s gross margins rose slightly over the period (to 46.6%). This was in part thanks to the company switching manufacturing to Asia during last year’s crisis.

Ahead of expectations

With an order book of over £150m, XP is predicting that the recent trading momentum will continue into the second half of its financial year. As a result, the Singapore-based business now thinks its full-year results will be “modestly ahead” of what analysts were forecasting. Naturally, investors would probably prefer words like ‘materially ahead’. However, this does provide management with a bit of wiggle room if trading turns out to be better than expected.

As a further sign of confidence, XP announced today that it would be returning 37p per share in dividends to owners for the half year. This represents just over double what holders received for the first half of 2020. 

FTSE 250 beater?

XP’s share price has significantly underperformed the FTSE 250 over the last year. In other words, investors could have achieved a far better return by simply buying a passive fund that tracks the return of the index.

Then again, one gets a completely different perspective when looking at performance over a longer time period. From July 2016 to today, XPP’s share price has climbed a little under 220%. The FTSE 250 is up just 33%. This shows how deviating from tracking the index has the potential to dramatically improve my wealth over the medium to long term.

While we can’t assume that investors will get similar gains going forward, XPP’s growth prospects do look compelling. Today, Chairman James Peters remarked that the company had “exposure to secular growth trends related to Big Data, Artificial Intelligence, the Internet of Things and the Fourth Industrial Revolution”. New products and markets give the company “the potential for further market share gains”, he said.

This is not to say that XPP is devoid of near-term obstacles. Issues connected to the supply of components may continue. Increased freight costs are already starting to have an impact, according to the company.

As stated last month, the shares aren’t exactly cheap on 27 times earnings either. One suspects highly-rated shares like XPP could be hit hard if the global economic recovery were to slow.

Top growth stock

Taking into account its potential, great margins, ‘sticky’ clients and sound finances, however, I’d buy this stock over a FTSE 250 tracker today. 

As far as growth stocks go, I reckon XP Power is up there with the best of them.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has recommended XP Power. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing Articles

Is the S&P 500 going to 10,000 by 2030? This expert thinks so

One stock market strategist sees animal spirits taking hold and driving the S&P 500 index even higher by the end…

Read more »